Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
Critical Reviews™ in Therapeutic Drug Carrier Systems
Factor de Impacto: 2.9 Factor de Impacto de 5 años: 3.72 SJR: 0.736 SNIP: 0.551 CiteScore™: 2.43

ISSN Imprimir: 0743-4863
ISSN En Línea: 2162-660X

Volumes:
Volumen 36, 2019 Volumen 35, 2018 Volumen 34, 2017 Volumen 33, 2016 Volumen 32, 2015 Volumen 31, 2014 Volumen 30, 2013 Volumen 29, 2012 Volumen 28, 2011 Volumen 27, 2010 Volumen 26, 2009 Volumen 25, 2008 Volumen 24, 2007 Volumen 23, 2006 Volumen 22, 2005 Volumen 21, 2004 Volumen 20, 2003 Volumen 19, 2002 Volumen 18, 2001 Volumen 17, 2000 Volumen 16, 1999 Volumen 15, 1998 Volumen 14, 1997 Volumen 13, 1996 Volumen 12, 1995

Critical Reviews™ in Therapeutic Drug Carrier Systems

DOI: 10.1615/CritRevTherDrugCarrierSyst.v18.i5.30
24 pages

Transcutaneous Immunization: An Emerging Route of Immunization and Potent Immunostimulation Strategy

Scott A. Hammond
IOMAI Corporation, 20 Firstfield Rd., Suite 250, Gaithersburg MD 20878
Mimi Guebre-Xabier
IOMAI Corporation, 20 Firstfield Rd., Suite 250, Gaithersburg MD 20878
Jianmei Yu
IOMAI Corporation, 20 Firstfield Rd., Suite 250, Gaithersburg MD 20878
Gregory M. Glenn
IOMAI Corporation, 20 Firstfield Rd., Suite 250, Gaithersburg MD 20878

SINOPSIS

Transcutaneous immunization (TCI) has emerged recently as a new method of vaccination that uses the skin. The simplicity of a patch-based immunization may obscure the potency of this strategy for immunostimulation because TCI allows the safe use of a wide variety of potent adjuvants. It is thought that these adjuvants activate Langerhans cells in the skin, which migrate to the draining lymph to orchestrate robust systemic immune responses. TCI represents a novel combination using established knowledge relating to skin penetration, the potency of adjuvant-based immunostimulation, and data showing that Langerhans cells are highly desirable targets because of their antigen-presenting cell function. The near-term challenge will be to take this promising insight into successful product development.


Articles with similar content:

The Role of the Lkb1/AMPK Pathway in Hematopoietic Stem Cells and Leukemia
Critical Reviews™ in Oncogenesis, Vol.19, 2014, issue 5
Daisuke Nakada, Yusuke Saito
Nanoparticulate Carriers Used as Vaccine Adjuvant Delivery Systems
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.36, 2019, issue 5
Rui Qian, Ting Liu, Tingni Wu, Ning Wang, Ting Wang
Victory and Defeat in the Induction of a Therapeutic Response through Vaccine Therapy for Human and Canine Brain Tumors: A Review of the State of the Art
Critical Reviews™ in Immunology, Vol.34, 2014, issue 5
Nate N. Waldron , G Elizabeth Pluhar, Rob Shaver, Brian M. Andersen, Michael R. Olin, Christopher L. Moertel
Regulation of Immune Responses of the Intestinal Mucosa
Critical Reviews™ in Immunology, Vol.16, 1996, issue 3
Stephan R. Targan, Maria T. Abreu-Martin
Dendritic Cell-Based Vaccines: From Mouse Models to Clinical Cancer Immunotherapy
Critical Reviews™ in Oncogenesis, Vol.11, 2000, issue 1
Carl G. Figdor, Gosse J. Adema, Marco W. J. Schreurs, Andreas A. O. Eggert, Cornells J. A. Punt